
-
2006
Company Description
Tioma Therapeutics is a venture-stage biopharmaceutical company
Formerly Known as Vasculox. Tioma is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. Our functionally diverse antibodies represent a new class of checkpoint inhibitors that harness both the adaptive and innate immune responses.
-
Manufacturer:
Science and Engineering -
Formed:
2006 -
Company Website:
-
Company E-mail:
-
Company Address:
4320 Forest Park Avenue, Suite 304St Louis, MOUnited States -
CEO:
- Robert Karr
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits